The novel coronavirus disease 2019 (COVID-19) has infected more than 100 million people
globally within the first year of the pandemic. With a death toll surpassing 500,000 in the …

Coronavirus 2019 (COVID-19) has created a global pandemic that is devastating human
lives, public healthcare systems, and global economies. Multiple effective and safe COVID …

Background Pregnant and lactating women were excluded from initial coronavirus disease
2019 vaccine trials; thus, data to guide vaccine decision making are lacking. Objective This …

As the COVID-19 pandemic continues into its third year, emerging data indicates increased
risks associated with SARS-CoV-2 infection during pregnancy, including pre-eclampsia …

Biological sex affects the outcome of diverse respiratory viral infections. The pathogenesis of
respiratory infections caused by viruses ranging from respiratory syncytial virus to influenza …

Background: The coronavirus disease 2019 (COVID-19) pandemic has given rise to the
need to develop a vaccine as quickly as possible. As pregnant women are at increased risk …

BACKGROUND Since coronavirus disease 2019 vaccines have been distributed, a debate
has raised on whether pregnant women should get the vaccine. No available data exist so …

A year after the initial outbreak of Covid-19 pandemic, several Phase III clinical trials
investigating vaccine safety and efficacy have been published. These vaccine candidates …

The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

Viral infections during pregnancy are associated with significant adverse perinatal and fetal
outcomes. Pregnancy is a unique immunologic and physiologic state, which can influence …